All the Latest Game Footage and Images from Stack & Sort Pals Stack & Sort Pals is a fun and addictive puzzle game where you sort colorful blocks, each representing a cute animal, into perfectly ...
Earlier this year, Canada became the first major market in the world where generic forms of semaglutide became legal. The competition was on: Manufacturers raced to secure Health Canada approval so ...
The price of Canada’s best-selling drug, Ozempic, is starting to plummet. Generic forms of semaglutide, the active ingredient in Ozempic, have begun to hit pharmacy shelves. The first product widely ...
Some Canadians will be able to buy brand-name GLP-1 drug Ozempic at a reduced price, Danish drugmaker Novo Nordisk said in a statement Tuesday. The move comes as two generic versions of Ozempic and ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Health Canada ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Some Canadian ...
WASHINGTON, May 18 (Reuters) - U.S. President Donald Trump said on Monday that TrumpRx.gov, a government-backed website that lists discounted prescription drugs, will begin featuring generic medicines ...
The Washington Wizards will have the No. 1 pick in the 2026 NBA Draft. The Wizards won the 2026 NBA Draft Lottery on Sunday afternoon, winning the draw to pick first overall with 14% odds. The Jazz, ...
The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday. Generics of the SGLT2 inhibitor are indicated for glycemic ...
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...
After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.